SCHEMBL30709372

SCHEMBL30709372

N#Cc1ccc2c(c1)c1ccccc1n2-c1nc(-n2c3ccccc3c3cc(C#N)ccc32)c(-n2c3ccccc3c3cc(C#N)ccc32)c(-c2ccccc2-c2cccc(-c3ccccc3)n2)c1-n1c2ccccc2c2cc(C#N)ccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 3/20 0.34
CSF1R P07333 2/20 0.34
JAK2 O60674 1/20 0.34
PRKD3 O94806 1/20 0.34
ABL1 P00519 1/20 0.34
EGFR P00533 1/20 0.34
ERBB2 P04626 1/20 0.34
LCK P06239 1/20 0.34
CDK1 P06493 1/20 0.34
LYN P07948 1/20 0.34
RET P07949 1/20 0.34
KIT P10721 1/20 0.34
FGFR1 P11362 1/20 0.34
FER P16591 1/20 0.34
FLT1 P17948 1/20 0.34
FGFR3 P22607 1/20 0.34
KDR P35968 1/20 0.34
FLT3 P36888 1/20 0.34
FRK P42685 1/20 0.34
SYK P43405 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30709345 0.91 ABCG2 (0.36) CLK4CSF1RJAK2PRKD3ABL1
SCHEMBL30709480 0.88 MYC (0.38) CLK4CSF1RJAK2PRKD3ABL1
SCHEMBL30709495 0.87 KMT2A (0.42) MEN1KMT2ARAB9AKDM4E
SCHEMBL22148674 0.86 MEN1 (0.36) MEN1KMT2ARAB9A
SCHEMBL30709223 0.86 METAP2 (0.38) ABCG2TSHRRAB9AALDH1A1KDM4E
SCHEMBL22148523 0.86 CYP1A2 (0.36) CLK4ABCG2ABCB1CYP1A2CYP3A4
SCHEMBL30709469 0.86 ABCG2 (0.41) CLK4CSF1RJAK2PRKD3ABL1
SCHEMBL30561030 0.85 MEN1 (0.38) CLK4CSF1RJAK2PRKD3ABL1
SCHEMBL22148589 0.85 ALDH1A1 (0.36) FLT3LMNAMEN1KMT2ARAB9A
SCHEMBL30709583 0.84 CSF1R (0.34) CLK4CSF1RJAK2PRKD3ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11849634-B2 Composition of matter for use in organic light- emitting diodes KYULUX, INC. (JP) 2023-12-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11849634-B2 Composition of matter for use in organic light- emitting diodes NDUFV3, NDUFV2, CRY2 CLK4 4169/4885CSF1R 3614/4885JAK2 4534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.